Viewing StudyNCT02572453



Ignite Creation Date: 2024-05-06 @ 7:39 AM
Last Modification Date: 2024-10-26 @ 11:50 AM
Study NCT ID: NCT02572453
Status: TERMINATED
Last Update Posted: 2022-09-13
First Post: 2015-10-08

Brief Title: Phase 2 Study of AT13387 Onalespib in ALK ALCL MCL and BCL-6 DLBCL
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-04-04
Start Date Type: ACTUAL
Primary Completion Date: 2021-03-18
Primary Completion Date Type: ACTUAL
Completion Date: 2021-03-18
Completion Date Type: ACTUAL
First Submit Date: 2015-10-08
First Submit QC Date: October 8 2015
Study First Post Date: 2015-10-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2022-09-13
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-08-15
Last Update Post Date: 2022-09-13
Last Update Post Date Type: ACTUAL